Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122721) titled 'The effect of neostigmine reversal on residual postoperative neuromuscular blockade under quantitative monitoring' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiangya Hospital of Central South University
Condition:
Gastrointestinal tumors
Intervention:
Regular group:Intraoperative neuromuscular monitoring is performed. Neuromuscular blocking agents are supplemented according to the TOF value (if the TOF count is >= 2, 1/3 to 1/2 of the induction dose of neuromuscular blocking agent can be added) or surgical needs. Neuromuscular monitoring is continued upon arrival...